- carcinomas".
Anticancer Res. 22 (6A): 3331–5. PMID 12530083.
Krapfenbauer K,
Engidawork E,
Cairns N,
Fountoulakis M,
Lubec G (2003). "Aberrant
expression of peroxiredoxin...
- doi:10.1034/j.1600-0404.2000.00310.x. PMID 11261808. S2CID 39916984.
Engidawork E,
Gulesserian T,
Balic N, et al. (2002). "Changes in
nicotinic acetylcholine...
- 249–58. doi:10.1006/bbrc.2000.4109. PMID 11162507. Yoo BC,
Vlkolinsky R,
Engidawork E,
Cairns N,
Fountoulakis M,
Lubec G (Apr 2001). "Differential expression...
- doi:10.1073/pnas.182384499. PMC 129315. PMID 12193653.
Krapfenbauer K,
Engidawork E,
Cairns N,
Fountoulakis M,
Lubec G (March 2003). "Aberrant expression...
- Chem. 276 (30): 28281–90. doi:10.1074/jbc.M011549200. PMID 11352901.
Engidawork E,
Gulesserian T,
Balic N, et al. (2002). "Changes in
nicotinic acetylcholine...
- 11 (5): 677–84. doi:10.1101/gr.gr-1640r. PMC 311086. PMID 11337467.
Engidawork E,
Juranville JF,
Fountoulakis M,
Dierssen M,
Lubec G (2001). "Selective...
- doi:10.1261/rna.5660803. PMC 1370459. PMID 12869704.
Gulesserian T,
Engidawork E,
Fountoulakis M,
Lubec G (2004). "Decreased
brain levels of
Lupus La...
- 108)105:1<20::AID-AJMG1047>3.0.CO;2-C. PMID 11424985. S2CID 37412240.
Engidawork E,
Gulesserian T,
Balic N,
Cairns N,
Lubec G (2001). "Changes in nicotinic...
- activity". Cell
Growth & Differentiation. 12 (1): 29–37. PMID 11205743.
Engidawork E,
Juranville JF,
Fountoulakis M,
Dierssen M,
Lubec G (2001). "Selective...
- activity". Cell
Growth & Differentiation. 12 (1): 29–37. PMID 11205743.
Engidawork E,
Juranville JF,
Fountoulakis M,
Dierssen M,
Lubec G (2001). "Selective...
